Nordea Investment Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-110,053
Closed -$3.03M 1005
2021
Q2
$3.03M Buy
+110,053
New +$2.16M ﹤0.01% 652

Nordea Investment Management's TBIO Position: Q3 2021 in Review

Nordea Investment Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 110,053 shares — an estimated $3.03M sold.

Nordea Investment Management first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $3.03M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Nordea Investment Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Nordea Investment Management sold 110,053 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $3.03M.
  • Nordea Investment Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Nordea Investment Management's Translate Bio, Inc. Common Stock position peaked at $3.03M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Nordea Investment Management's 13F filing for Q3 2021, filed 1 Nov 2021.